Lupron depot-3 and Weakness - from FDA reports


Summary

Weakness is found among people who take Lupron depot-3, especially for people who are male, 60+ old , have been taking the drug for < 1 month, also take medication Dilaudid, and have Prostate cancer. This review analyzes which people have Weakness with Lupron depot-3. It is created by eHealthMe based on reports of 500 people who have side effects when taking Lupron depot-3 from FDA , and is updated regularly.

What to expect?

If you take Lupron depot-3 and have Weakness, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Lupron depot-3 and have Weakness

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 12, 2017

500 people reported to have side effects when taking Lupron depot-3.
Among them, 52 people (10.4%) have Weakness


Number of reports submitted per year:

Could Lupron depot-3 cause Weakness?

Time on Lupron depot-3 when people have Weakness *:

  • < 1 month: 36.36 %
  • 1 - 6 months: 31.82 %
  • 6 - 12 months: 22.73 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 4.55 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 4.55 %

Gender of people who have Weakness when taking Lupron depot-3 *:

  • female: 42.31 %
  • male: 57.69 %

Age of people who have Weakness when taking Lupron depot-3 *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 10.42 %
  • 20-29: 12.5 %
  • 30-39: 16.67 %
  • 40-49: 8.33 %
  • 50-59: 2.08 %
  • 60+: 50.0 %

Top conditions involved for these people *:

  • Prostate Cancer (12 people, 23.08%)
  • High Blood Cholesterol (4 people, 7.69%)
  • Precocious Puberty (3 people, 5.77%)
  • Prostate Cancer Metastatic (2 people, 3.85%)
  • Ovarian Cysts (1 person, 1.92%)

Top co-used drugs for these people *:

  • Fentanyl (7 people, 13.46%)
  • Dilaudid (7 people, 13.46%)
  • Lipitor (5 people, 9.62%)
  • Casodex (5 people, 9.62%)
  • Fosamax (4 people, 7.69%)

Top other side effects for these people *:

  • Confusion (13 people, 25.00%)
  • Dizziness (11 people, 21.15%)
  • Nausea (10 people, 19.23%)
  • Fatigue (10 people, 19.23%)
  • Stomatitis (8 people, 15.38%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Weakness when taking Lupron depot-3?

Expand the study to include all drugs with the same ingredients

Weakness and drugs with ingredients of leuprolide acetate.

Expand the study to include reports from both FDA and eHealthMe

Weakness and Lupron depot-3 from FDA and eHealthMe reports

Lupron depot-3

Lupron depot-3 has active ingredients of leuprolide acetate. It is often used in endometriosis. (latest outcomes from Lupron depot-3 526 users)

Weakness

Weakness has been reported by people with multiple sclerosis, high blood pressure, high blood cholesterol (latest reports from 303,647 Weakness patients).

Browse all side effects of Lupron depot-3

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Weakness

Weakness

Could your condition cause Weakness

Weakness

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Lupron depot-3 and have Weakness.

Questions to the study

More questions >

User reviews to the study

More reviews >